Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myoview Single vs Dual Isotope SPECT in CAD
NCT00381316Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of technetium Tc 99m tetrofosmin in coronary artery disease (CAD) (2 arms), sponsored by GE HealthCare. Primary endpoint: Diagnostic Equivalence of Dual-Isotope and Single-Isotope SPECT. Started Jul 2006; status: completed.
02
Drugs
technetium Tc 99m tetrofosmin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00381316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381316.